Kp. Spindler et al., REGIONAL MITOGENIC RESPONSE OF THE MENISCUS TO PLATELET-DERIVED GROWTH-FACTOR (PDGF-AB), Journal of orthopaedic research, 13(2), 1995, pp. 201-207
Since meniscal healing is region-specific, we studied the regional (pe
ripheral compared with central) response of meniscal explants to human
, recombinant platelet-derived growth factor-AB. Meniscal explants fro
m the hindlimbs of both knees of mature sheep were sectioned and were
cultured with variable doses of human, recombinant platelet-derived gr
owth factor-AB, and incorporation of [H-3]-thymidine was measured. The
mitogenic response was measured at different times in culture (48 or
96 hours) and by location (lateral or medial). In the absence of the g
rowth factor, the peripheral third of both menisci incorporated 10-fol
d more [H-3]-thymidine on a weight basis than did the central two-thir
ds. Cellularity was equivalent in the two regions. Doses of less than
100 ng/ml of growth factor produced either no stimulation or a variabl
e response. A dose of 100 ng/ml resulted in consistent, significant (p
< 0.05) stimulation in all groups in the peripheral region, and a dos
e of 200 ng/ml provided more than a 2.5-fold increase. Multiple-factor
analysis of variance demonstrated that there were no significant diff
erences between experiments, times in culture, or menisci. The central
region did not respond to stimulation with the growth factor at any o
f the doses tested. These data suggest that regional differences (peri
pheral compared with central) in responsiveness to human, recombinant
platelet-derived growth factor-AB may reflect a different level of sig
nal transduction machinery for growth factor receptors and distinct fi
brochondrocyte populations. These findings are consistent with the var
iable healing capacity of the meniscal regions in vivo and suggest a p
harmacological means to promote the repair of the peripheral meniscal
region.